Quarterly ResultMay 7, 2026, 04:23 PM
Quantum-Si Q1 Revenue $258K; Net Loss $21.7M; Proteus Progress
AI Summary
Quantum-Si reported first quarter 2026 financial results with revenue of $258,000 and a net loss of $21.7 million. The company highlighted significant progress in the development of its Proteus™ instrument, including successful sequencing on integrated instruments and detecting 17 amino acids with its developmental kit. Quantum-Si reiterated its full-year 2026 financial guidance, anticipating approximately $1.0 million in revenue and total cash usage of $93.0 million or less. A commercial launch of Proteus is expected by the end of 2026.
Key Highlights
- Q1 2026 revenue was $258,000, down from $842,000 in Q1 2025.
- Net loss for Q1 2026 increased to $21.7 million from $19.2 million in Q1 2025.
- Adjusted EBITDA improved to negative $20.1 million in Q1 2026 from negative $21.5 million in Q1 2025.
- Achieved successful sequencing on integrated Proteus™ instruments.
- Current Proteus developmental sequencing kit detects 17 amino acids.
- Cash and cash equivalents and investments totaled $190.4 million as of March 31, 2026, providing runway into Q2 2028.
- Reiterated 2026 revenue guidance of approximately $1.0 million.
- Reiterated 2026 total cash usage guidance of $93.0 million or less.